ClinicalTrials.Veeva

Menu

The Role of the Fujinon Intelligent Chromo Endoscopy (FICE™) in Barrett's Esophagus

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Barrett's Esophagus

Study type

Observational

Funder types

Other

Identifiers

NCT01084629
07-006981

Details and patient eligibility

About

The purpose of this study to assess post ablation, if there are areas of Barrett's mucosa post ablation and to assess the ability of the Fujinon FICE system to detect this, as compared to white light endoscopy. A subgroup will also be compared with laser confocal microscopy

Enrollment

50 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Visible Barrett's esophagus
  • Scheduled for Surveillance Endoscopy
  • Able to undergo endoscopy

Exclusion criteria

  • Unable to undergo endoscopy
  • Unable to stop blood thinning medications

Trial design

50 participants in 2 patient groups

Surveillance Barrett's esophagus
Description:
Patients scheduled for endoscopic surveillance of Barrett's esophagus
Barrett's esophagus post ablation
Description:
Patients scheduled for surveillance endoscopy who have undergone ablative therapies (PDT, RF ablation) for their Barrett's esophagus

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems